Multi-omics analysis reveals CLEC2A is a leukemia-restricted CART target in KMT2A-rearranged Acute Myeloid LeukemiaDanielle Kirkey, Soheil Meshinchi|Research Square|2025Cited by 0
Post Hematopoietic Cell Transplantation Maintenance Therapy With Low-Dose Azacitidine in a Pediatric Population With High-Risk Myeloid MalignanciesEmily Merkel, Ann Dahlberg, Monica S. Thakar et al.|Transplantation and Cellular Therapy|2025Cited by 0